Literature DB >> 6627682

Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.

J J Stĕpan, E Silinková-Málková, T Havránek, J Formánková, M Zichová, J Lachmanová, M Straková, P Broulik, V Pacovský.   

Abstract

In 46 patients with primary hyperparathyroidism, in 21 non-dialysed patients with advanced renal failure, and in 52 patients on hemodialysis, a significant positive correlation was found between bone isoenzyme of serum alkaline phosphatase and plasma tartrate resistant acid phosphatase. In primary hyperparathyroidism, a significant positive correlation was found between the radiological degree of osteodystrophy and the biochemical parameters of bone remodelling. After removal of the parathyroid adenoma, only the tartrate-resistant acid phosphatase decreased to normal limits. Plasma tartrate resistant acid phosphatase was most significantly influenced by serum immunoreactive parathyroid hormone levels. In chronic renal failure, bone isoenzyme of serum alkaline phosphatase was most significantly influenced by serum immunoreactive parathyroid hormone levels, by hypocalcemia and by duration of hemodialysis. The results confirm that in hyperparathyroidism the extent of the whole-body rates of bone resorption and formation are approximately equal. The biochemical parameters can be used for serial assessment of the course of the disease but are not specific for diagnosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6627682     DOI: 10.1016/0009-8981(83)90404-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  15 in total

Review 1.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

2.  Improved methods for testing antiresorptive compounds in human osteoclast cultures.

Authors:  Jukka P Rissanen; Hannele Ylipahkala; Katja M Fagerlund; Clive Long; H Kalervo Väänänen; Jussi M Halleen
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

3.  Serum tartrate-resistant acid phosphatase (TRAP) as a biochemical marker of bone remodeling.

Authors:  H Rico; L F Villa
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

4.  Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.

Authors:  C de la Piedra; R Torres; A Rapado; M Diaz Curiel; N Castro
Journal:  Calcif Tissue Int       Date:  1989-07       Impact factor: 4.333

5.  The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone.

Authors:  J J Stĕpán; J Pospíchal; V Schreiber; J Kanka; J Mensík; J Presl; V Pacovský
Journal:  Calcif Tissue Int       Date:  1989-11       Impact factor: 4.333

6.  Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism.

Authors:  M Katagiri; T Ohtawa; M Fukunaga; T Harada
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Evaluation of the usefulness of serum phosphatases and osteocalcin as serum markers in a calcium depletion-repletion rat model.

Authors:  H Tanimoto; K H Lau; S K Nishimoto; J E Wergedal; D J Baylink
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

Review 8.  Biochemical markers of bone turnover for the clinical investigation of osteoporosis.

Authors:  P D Delmas
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

9.  Hydrochlorothiazide inhibits parathormone-stimulated increase in plasma tartrate-resistant acid phosphatase in mice.

Authors:  P D Broulik; V Pacovský
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

10.  Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.

Authors:  R Torres; C de la Piedra; A Rapado
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.